-
April 11, 2022 New Study Links Psilocybin to Lower Risk of Opioid AddictionResearchers attempt to replicate findings from a 2017 study that found classic psychedelic use conferred...
-
April 8, 2022 Drinking to Excess? Psychedelics Can HelpClearmind Medicine CEO Adi Zuloff-Shani writes this guest blog about how a new psychoactive molecule...
-
April 8, 2022 Psychedelic Business Spotlight – April 8This week in psychedelic business news: Field Trip Health secures a patent; Core One Labs...
-
April 7, 2022 Attend Canada’s Premiere Psychedelics Conference From Anywhere in the WorldThe 3rd annual Psychedelics Catalyst Summit at Queen’s University in Kingston, Ontario, will be available...
-
April 7, 2022 Mushrooms Have Their Own Language, New Study SuggestsThe electric pulses could be organized into “trains” that resemble human words, and a vocabulary...
-
April 1, 2022 Psychedelic Business Spotlight – April 1This week in psychedelic business news: TripSitter expands; Enveric files a major patent; and Psychedelic...
-
March 31, 2022 How to Enroll in a Psychedelic Clinical Trial in 5 Easy StepsInterested in participating in a psychedelic study? Here's an in-depth walk through guide so you...
-
March 30, 2022 5 Most Important Psychedelic Clinical Trials in 2022Here's why we think MAPS’ second Phase 3 MDMA trial is the most important psychedelic...
-
March 29, 2022 A Data-Driven Guide to Microdosing PsychedelicsThe Director of Research for Unlimited Sciences takes a deep dive into microdosing research to...
-
March 25, 2022 Interested in Psychedelic Stocks? This Is the BEST Resource for YouIntroducing the Benzinga Psychedelics Capital Conference on April 19 in Miami Beach,
